The making of biotech drugs: pampered Samurai cells, nuclear-zone security, and zero scope for error
A person tracks processes on a monitor at a biotech drug manufacturing site; image credit: Enzene
Synopsis
Tablets, capsules, or syrups are based on chemical synthesis and easier to make, but biotechnology drugs are a different ball game. They need sophisticated systems with no chance for error. A modern biotech facility needs scientific talent and millions of dollars in investment. It is also where engineered cells are prepped to fight off malignant cancers and other disorders.
Covered in spotless white hazmat suits from head to toe, they silently toil for hours. Inside a biotech facility, the staff are engrossed in their daily tasks. They track the readings flashing on their computer monitors. The computers are hooked to a chaotic jumble of machines, gleaming steel cylinders, and tubes at the other end of the shop floor. Somewhere inside this colossal set-up are millions of micro-sized cells jostling to grow fast.
Refer & Earn
Get Unlimited Access to The Economic Times
